- Straatman Jennifer, van der Wielen Nicole, Cuesta Miguel A., Daams Freek, Roig Garcia Josep, Bonavina Luigi, Rosman Camiel, van Berge Henegouwen Mark I., Gisbertz Suzanne S., van der Peet Donald L. Minimally Invasive Versus Open Esophageal Resection Three-year Follow-up of the Previously Reported Randomized Controlled Trial: the TIME Trial Annals of surgery 2017;266 (2):232-236 [PubMed]
- Shapiro Joel, van Lanschot J. Jan B., Hulshof Maarten C. C. M., van Hagen Pieter, van Berge Henegouwen Mark I., Wijnhoven Bas P. L., van Laarhoven Hanneke W. M., Nieuwenhuijzen Grard A. P., Hospers Geke A. P., Bonenkamp Johannes J., Cuesta Miguel A., Blaisse Reinoud J. B., Busch Olivier R. C., ten Kate Fiebo J. W., Creemers Geert-Jan M., Punt Cornelis J. A., Plukker John Th M., Verheul Henk M. W., Bilgen Ernst J. Spillenaar, van Dekken Herman, van der Sangen Maurice J. C., Rozema Tom, Biermann Katharina, Beukema Jannet C., Piet Anna H. M., van Rij Caroline M., Reinders Janny G., Tilanus Hugo W., Steyerberg Ewout W., van der Gaast Ate Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial lancet oncology 2015;16 (9):1090-1098 [PubMed]
- Oppedijk Vera, van der Gaast Ate, van Lanschot Jan J. B., van Hagen Pieter, van Os Rob, van Rij Caroline M., van der Sangen Maurice J., Beukema Jannet C., Rütten Heidi, Spruit Patty H., Reinders Janny G., Richel Dick J., van Berge Henegouwen Mark I., Hulshof Maarten C. C. M. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials Journal of clinical oncology 2014;32 (5):385-391 [PubMed]
- Biere Surya S. A. Y., van Berge Henegouwen Mark I., Maas Kirsten W., Bonavina Luigi, Rosman Camiel, Garcia Josep Roig, Gisbertz Suzanne S., Klinkenbijl Jean H. G., Hollmann Markus W., de Lange Elly S. M., Bonjer H. Jaap, van der Peet Donald L., Cuesta Miguel A. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial Lancet 2012;379 (9829):1887-1892 [PubMed]
- van Hagen P., Hulshof M. C. C. M., van Lanschot J. J. B., Steyerberg E. W., van Berge Henegouwen M. I., Wijnhoven B. P. L., Richel D. J., Nieuwenhuijzen G. A. P., Hospers G. A. P., Bonenkamp J. J., Cuesta M. A., Blaisse R. J. B., Busch O. R. C., ten Kate F. J. W., Creemers G.-J., Punt C. J. A., Plukker J. T. M., Verheul H. M. W., Spillenaar Bilgen E. J., van Dekken H., van der Sangen M. J. C., Rozema T., Biermann K., Beukema J. C., Piet A. H. M., van Rij C. M., Reinders J. G., Tilanus H. W., van der Gaast A., Bergman J. J. G. H. M., Bartelsman J. F., Bissumbar A., Blom R. L., Geijsen E. D., van Heijl M., Obertop H., Koning C. C. E., Offerhaus G. J., Omloo J. M., Wilmink H., Aparicio Pages M. N., van den Nieuwenhof-Biesheuvel L., Eijkenboom W. M. H., Koppert L. B., Meijer D. A., Siersema P. D., Spaander M. C. V., Verheij C., Vollebregt C., van Krieken J. H. J. M. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer New England journal of medicine 2012;366 (22):2074-2084 [PubMed]
Prof. MD PhD M.I. van Berge Henegouwen (Outcome Improvement in Esophago- Gastric Surgery)
Esophageal and gastric surgery is major GI surgery with high morbidity and a high postoperative recurrence rate of disease.
The research line focuses on direct postoperative care and improvenment through 1. new minimally invasive techniques, 2. better pre and postoperative care (rehabilitation), 3. evaluation of Quality of Life. Furthermore research gives insight in neo adjuvant techniques and evaluation of tumor response.
Other focus is on improving outcome of esophageal and gastric cancer care on a national level through research with the Dutch Upper GI Cancer Audit (DUCA).
PhD Students
MD A. Mertens
MD G. Pirozolo
L. Sadeh
MD L. van der Werf
- Johnson & Johnson Medical BV
- Maag, Lever, Darm Stichting
- NIEUWE DEB IND
- Olympus Nederland B.V.
- Stichting AMC Foundation (Vrijgesteld)
- ZonMw